Abstract
BackgroundPulmonary involvement is one of the major causes of morbidity and mortality in patients with progressive systemic sclerosis (PSS). Clinically significant interstitial lung disease (ILD) is noted in 25% of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
